Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.

Li XY, Moesta AK, Xiao C, Nakamura K, Casey M, Zhang H, Madore J, Lepletier A, Aguilera AR, Sundarrajan A, Jacoberger-Foissac C, Wong C, Dela Cruz T, Welch M, Lerner AG, Spatola BN, Soros VB, Corbin J, Anderson AC, Effern M, Hölzel M, Robson SC, Johnston RL, Waddell N, Smith C, Bald T, Geetha N, Beers C, Teng MWL, Smyth MJ.

Cancer Discov. 2019 Nov 7. doi: 10.1158/2159-8290.CD-19-0541. [Epub ahead of print]


CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function.

Mittal D, Lepletier A, Madore J, Aguilera AR, Stannard K, Blake SJ, Whitehall VLJ, Liu C, Bettington ML, Takeda K, Long GV, Scolyer RA, Lan R, Siemers N, Korman A, Teng MWL, Johnston RJ, Dougall WC, Smyth MJ.

Cancer Immunol Res. 2019 Apr;7(4):559-571. doi: 10.1158/2326-6066.CIR-18-0637. Epub 2019 Mar 20.


Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis.

Harjunpää H, Blake SJ, Ahern E, Allen S, Liu J, Yan J, Lutzky V, Takeda K, Aguilera AR, Guillerey C, Mittal D, Li XY, Dougall WC, Smyth MJ, Teng MWL.

Oncoimmunology. 2018 Mar 26;7(7):e1445949. doi: 10.1080/2162402X.2018.1445949. eCollection 2018.


CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

Li XY, Das I, Lepletier A, Addala V, Bald T, Stannard K, Barkauskas D, Liu J, Aguilera AR, Takeda K, Braun M, Nakamura K, Jacquelin S, Lane SW, Teng MW, Dougall WC, Smyth MJ.

J Clin Invest. 2018 Jun 1;128(6):2613-2625. doi: 10.1172/JCI98769. Epub 2018 May 14.


Interleukin-12 from CD103+ Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of Metastasis.

Mittal D, Vijayan D, Putz EM, Aguilera AR, Markey KA, Straube J, Kazakoff S, Nutt SL, Takeda K, Hill GR, Waddell N, Smyth MJ.

Cancer Immunol Res. 2017 Dec;5(12):1098-1108. doi: 10.1158/2326-6066.CIR-17-0341. Epub 2017 Oct 25.


Modeling the impact of prostate edema on LDR brachytherapy: a Monte Carlo dosimetry study based on a 3D biphasic finite element biomechanical model.

Mountris KA, Bert J, Noailly J, Aguilera AR, Valeri A, Pradier O, Schick U, Promayon E, Ballester MA, Troccaz J, Visvikis D.

Phys Med Biol. 2017 Mar 21;62(6):2087-2102. doi: 10.1088/1361-6560/aa5d3a. Epub 2017 Jan 31.


Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy.

Blake SJ, Stannard K, Liu J, Allen S, Yong MC, Mittal D, Aguilera AR, Miles JJ, Lutzky VP, de Andrade LF, Martinet L, Colonna M, Takeda K, Kühnel F, Gurlevik E, Bernhardt G, Teng MW, Smyth MJ.

Cancer Discov. 2016 Apr;6(4):446-59. doi: 10.1158/2159-8290.CD-15-0944. Epub 2016 Jan 19.


The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis.

Herro R, Antunes RDS, Aguilera AR, Tamada K, Croft M.

J Invest Dermatol. 2015 Aug;135(8):2109-2118. doi: 10.1038/jid.2015.110. Epub 2015 Mar 19.


Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis.

Herro R, Da Silva Antunes R, Aguilera AR, Tamada K, Croft M.

J Allergy Clin Immunol. 2015 Sep;136(3):757-68. doi: 10.1016/j.jaci.2014.12.1936. Epub 2015 Feb 11.


3D Stationary electric current density in a spherical tumor treated with low direct current: an analytical solution.

Jiménez RP, Pupo AE, Cabrales JM, Joa JA, Cabrales LE, Nava JJ, Aguilera AR, Mateus MA, Jarque MV, Brooks SC.

Bioelectromagnetics. 2011 Feb;32(2):120-30. doi: 10.1002/bem.20611. Epub 2010 Oct 28.


Modified Gompertz equation for electrotherapy murine tumor growth kinetics: predictions and new hypotheses.

Cabrales LE, Nava JJ, Aguilera AR, Joa JA, Ciria HM, González MM, Salas MF, Jarque MV, González TR, Mateus MA, Brooks SC, Palencia FS, Zamora LO, Quevedo MC, Seringe SE, Cuitié VC, Cabrales IB, González GS.

BMC Cancer. 2010 Oct 28;10:589. doi: 10.1186/1471-2407-10-589.

Supplemental Content

Loading ...
Support Center